Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice

American Journal of Physiology - Renal Physiology

Volumn 310, Issue 8, 2016, Pages F785-F795

  Mulay, Shrikant R ^a   Eberhard, Jonathan N ^a   Pfann, Victoria ^b   Marschner, Julian A ^a   Darisipudi, Murthy N ^b   Daniel, Christoph ^b   Romoli, Simone ^a   Desai, Jyaysi ^a   Grigorescu, Melissa ^a   Kumar, Santhosh V ^a   Rathkolb, Birgit ^c,d   Wolf, Eckhard ^d   De Angelis, Martin Hrabě ^c,e,f   Bäuerle, Tobias ^g   Dietel, Barbara ^b   Wagner, Carsten A ^h   Amann, Kerstin ^b   Eckardt, Kai Uwe ^b   Aronson, Peter S ^a   Anders, Hans Joachim ^a   Knauf, Felix ^b,i   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular; CKD MBD; Hypertension; Oxalate; Renal failure

Indexed keywords

CREATININE; FIBROBLAST GROWTH FACTOR 23; NITROGEN; OXALIC ACID;

ANEMIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FIBROSING ALVEOLITIS; FIBROSIS; HEART MUSCLE FIBROSIS; HISTOLOGY; HYPERKALEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPERTENSION; INFLAMMATION; KIDNEY INJURY; MALE; METABOLIC ACIDOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; UREMIA; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE MODEL; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; HYPERTENSION; MICE; MICE, INBRED C57BL; MYOCARDIUM; OXALIC ACID; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 84983749182     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00488.2015     Document Type: Article

References (32)

1. Becker GJ, Hewitson TD. Animal models of chronic kidney disease: useful but not perfect. Nephrol Dial Transplant 28: 2432–2438, 2013.
2. Chevalier RL, Forbes MS. Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 19: 197–206, 2008.
3. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75: 1145–1152, 2009.
4. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature 509: 282–283, 2014.
5. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J, St Peter W, Guo H, Hu Y, Kats A, Li S, Li S, Maloney J, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L. US Renal Data System 2013. Annual Data Report. Am J Kidney Dis 63: A7, 2014.
6. Dai XY, Zhou L, Huang XR, Fu P, Lan HY. Smad7 protects against chronic aristolochic acid nephropathy in mice. Oncotarget 6: 11930–11944, 2015.
7. Diwan V, Small D, Kauter K, Gobe GC, Brown L. Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats. Am J Physiol Renal Physiol 307: F1169–F1178, 2014.
8. Fink M, Henry M, Tange JD. Experimental folic acid nephropathy. Pathology 19: 143–149, 1987.
9. Fiske CH, Subbarow Y. The colorimetric determination of phosphorous. J Biol Chem 66: 375–400, 1925.
10. Fiske CH, Subbarow Y. The nature of the “inorganic phosphate” in voluntary muscle. Science 65: 401–403, 1927.
11. Hennedige T, Koh TS, Hartono S, Yan YY, Song IC, Zheng L, Lee WS, Rumpel H, Martarello L, Khoo JB, Koh DM, Chuang KH, Thng CH. Intravoxel incoherent imaging of renal fibrosis induced in a murine model of unilateral ureteral obstruction. Magn Reson Imaging 33: 1324–1328, 2015.
12. Huang L, Scarpellini A, Funck M, Verderio EA, Johnson TS. Development of a chronic kidney disease model in C57BL/6 mice with relevance to human pathology. Nephron Extra 3: 12–29, 2013.
13. Jia T, Olauson H, Lindberg K, Amin R, Edvardsson K, Lindholm B, Andersson G, Wernerson A, Sabbagh Y, Schiavi S, Larsson TE. A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC Nephrol 14: 116, 2013.
14. Kim W, Moon SO, Lee SY, Jang KY, Cho CH, Koh GY, Choi KS, Yoon KH, Sung MJ, Kim DH, Lee S, Kang KP, Park SK. COMPangiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 17: 2474–2483, 2006.
15. Knauf F, Asplin JR, Granja I, Schmidt IM, Moeckel GW, David RJ, Flavell RA, Aronson PS. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int 84: 895–901, 2013.
16. Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 56: 333–337, 1999.
17. Lech M, Grobmayr R, Ryu M, Lorenz G, Hartter I, Mulay SR, Susanti HE, Kobayashi KS, Flavell RA, Anders HJ. Macrophage phenotype controls long-term AKI outcomes–kidney regeneration versus atrophy. J Am Soc Nephrol 25: 292–304, 2014.
18. Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, Mizel D, Zhou H, Wright EC, Kopp JB, Schnermann J, Yuen PS, Star RA. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int 78: 1136–1153, 2010.
19. Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K, Tomioka Y, Ito S, Soga T, Abe T. Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD. J Am Soc Nephrol 26: 1787–1794, 2015.
20. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun 28: 10274, 2016.
21. Mulay SR, Evan A, Anders HJ. Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant 29: 507–514, 2014.
22. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. J Clin Invest 123: 236–246, 2013.
23. Rathkolb B, Fuchs H, Gailus-Durner V, Aigner B, Wolf E, Hrabe de Angelis M. Blood collection from mice and hematological analyses on mouse blood. Curr Protoc Mouse Biol 3: 101–119, 2013.
24. Rathkolb B, Hans W, Prehn C, Fuchs H, Gailus-Durner V, Aigner B, Adamski J, Wolf E, Hrabe de Angelis M. Clinical chemistry and other laboratory tests on mouse plasma or serum. Curr Protoc Mouse Biol 3: 69–100, 2013.
25. Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging 6: 806–822, 2013.
26. Schreiber A, Shulhevich Y, Geraci S, Hesser J, Stsepankou D, Neudecker S, Koenig S, Heinrich R, Hoecklin F, Pill J, Friedemann J, Schweda F, Gretz N, Schock-Kusch D. Transcutaneous measurement of renal function in conscious mice. Am J Physiol Renal Physiol 303: F783–F788, 2012.
27. Stockelman MG, Lorenz JN, Smith FN, Boivin GP, Sahota A, Tischfield JA, Stambrook PJ. Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am J Physiol Renal Physiol 275: F154–F163, 1998.
28. Tanaka T, Doi K, Maeda-Mamiya R, Negishi K, Portilla D, Sugaya T, Fujita T, Noiri E. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am J Pathol 174: 1203–1211, 2009.
29. Ucero AC, Benito-Martin A, Izquierdo MC, Sanchez-Nino MD, Sanz AB, Ramos AM, Berzal S, Ruiz-Ortega M, Egido J, Ortiz A. Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol 46: 765–776, 2014.
30. Yang HC, Fogo AB. Mechanisms of disease reversal in focal and segmental glomerulosclerosis. Adv Chronic Kidney Dis 21: 442–447, 2014.
31. Yang HC, Zuo Y, Fogo AB. Models of chronic kidney disease. Drug Disc Today Dis Models 7: 13–19, 2010.
32. Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron 44: 230–234, 1986.